Journal profile · ONCOLOGY
Journal of Gastrointestinal Cancer
ISSN 1941-6628 · eISSN 1941-6636 · Springer Nature · 4 issues per year
Journal of Gastrointestinal Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2 (journal website); hybrid open access; APC about USD 4,190; median 106 days to acceptance (98 articles, last 24 months); 212 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Gastrointestinal Cancer is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research and Hepatocellular Carcinoma Treatment and Prognosis, together about 25.1% of its articles. Its main subfields are Oncology and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Gastrointestinal Cancer is a peer-reviewed multidisciplinary journal dedicated to understanding and treating cancers arising in the gastrointestinal tract. It publishes clinical and translational research that aids in the multidisciplinary management of cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, colon, rectum, and anus. The journal also publishes original interdisciplinary research on gastrointestinal cancer epidemiology, prevention, diagnosis, technology, and survivorship. State-of-the-art reviews on topics of immediate interest and clinical importance are provided by experts in their field. Editorials, case reports, letters to the editor, and other special items of interest are frequently published. Note that basic science and pre-clinical studies are no longer accepted in the Journal of Gastrointestinal Cancer. The journal is supported by a large international editorial board with broad expertise in gastrointestinal cancer research. We aim for as rapid peer-review as possible and maintain a hybrid publishing model that allows traditional subscription-based or open access publishing. Pre-submission inquiries can be sent to the editor-in-chief.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Jordan CloydPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine9%
- Pancreatic and Hepatic Oncology ResearchMedicine8.6%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine7.6%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine7.4%
- Gastrointestinal Tumor Research and TreatmentMedicine6.7%
- Colorectal Cancer Surgical TreatmentsMedicine5.7%
- Esophageal Cancer Research and TreatmentMedicine5.6%
- Colorectal Cancer Treatments and StudiesMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.8Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 736OpenAlex ·
- 2-year mean citedness
- 2.11OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 20.69%LetPub ·
Volume
- Articles per year
- 202LetPub ·
- Downloads per year (publisher) 2025
- 480,200Publisher website ·
Articles by year OpenAlex count · 2,547 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 228 | 55 | 89 |
| 2025 | 212 | 56 | 553 |
| 2024 | 152 | 40 | 609 |
| 2023 | 95 | 22 | 571 |
| 2022 | 128 | 26 | 778 |
| 2021 | 203 | 39 | 1,945 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
106 daysMedian, submission to acceptance · P25–P75 65 days – 138 days
- Acceptance to online
- median 7 days (98 articles)
- Submission to online
- median 120 days
- Sample
- 98 articles with submission and acceptance dates (486 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,190 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted18, with length limits
- brief communicationThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …Length not stated
- brief reportThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …main text ≤ 600 words · abstract ≤ 200 words
- case reportThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …main text ≤ 3,500 words · figures and tables ≤ 5
- case reportsAccepted case reports will describe novel, impactful, and/or educational findings focused on the multidisciplinary diagnosis, prevention, treatment, and/or foll…Length not stated
- commentThis article type denotes an agenda-setting, authoritative, informed and often provocative expert piece on topical issues relevant to the journal's readership.Length not stated
- correspondenceThis article type denotes timely comments on material published in the journal as well as anything of likely interest to the readers, such as policy debates and…main text ≤ 750 words · references ≤ 6
- editorialThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …main text ≤ 1,500 words · figures and tables ≤ 2
- editorialsThese articles are most often invited by the Editor. They discuss an article published in the Journal of Gastrointestinal Cancer and place the relevant issues i…Length not stated
- letters to the editorThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …Length not stated
- original articleThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …main text ≤ 6,000 words
- original researchThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …Length not stated
- perspectiveThis article type denotes a scholarly review and discussion of the primary research literature that does not meet the criteria for a review article. This could …main text ≤ 1,500 words · abstract ≤ 200 words · figures and tables ≤ 2 · references ≤ 10
- researchThis article type denotes a complete, comprehensive report of original research relevant to gastrointestinal cancers of the esophagus, stomach, duodenum, jejuno…Length not stated
- research highlightThis article type denotes an article that summarizes the findings of selected new research.Length not stated
- reviewThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …Length not stated
- review articleThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …main text ≤ 6,000 words · abstract ≤ 200 words · references ≤ 100
- review articlesThis article type denotes an authoritative, balanced, and scholarly survey aimed at informing a broad readership of developments in a field in which there have …Length not stated
- surveyThe Journal of Gastrointestinal Cancer publishes original research, review articles, brief communications, letters to the editor, editorials, case reports, and …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
Originality and exclusivity required at submission Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Optional data availability statement Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Ethics approval statement required for human/animal research Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permission required for previously published material Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Gastrointestinal Cancer, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 1941-6628
- Electronic ISSN
- 1941-6636
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Gastrointestinal Cancer
What CAS zone is Journal of Gastrointestinal Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Gastrointestinal Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Gastrointestinal Cancer?
The journal's website gives an impact factor of 2.2 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.4, h-index 48.
How long does peer review take at Journal of Gastrointestinal Cancer?
Based on the dates recorded on 98 articles published between September 2024 and September 2026 (the last 24 months), the median time from submission to acceptance is 106 days (interquartile range 65–138 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Gastrointestinal Cancer?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Journal of Gastrointestinal Cancer?
According to LetPub and DOAJ records, Journal of Gastrointestinal Cancer is indexed in ESCI and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Journal of Gastrointestinal Cancer open access, and what is the APC?
Journal of Gastrointestinal Cancer is a hybrid journal. For open-access publication: APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .